Skip to content

INguinal hernia: operative or Conservative Approach (INCA TRIAL)?

INguinal hernia: operative or Conservative Approach (INCA TRIAL)?

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON24130
Enrollment
800
Registered
2006-03-15
Start date
2006-03-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Operative correction of the inguinal hernia or observative management.

Sponsors

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Unilateral inguinal hernia; 2. Males; 3. Medial or lateral inguinal hernia; 4. Age >= 50 years; 5. Description I or II of pain or discomfort interfering with daily activity; 6. Primary or recurrent inguinal hernia; 7. Informed consent (addendum V).

Exclusion criteria

Exclusion criteria: 1. Gender: female; 2. Bilateral inguinal hernia; 3. Femoral hernia; 4. Description III or IV of pain or discomfort interfering with daily activity; 5. Acute hernia complication (bowel obstruction, incarceration, strangulation, peritonitis or perforation); 6. Patient classified as American Society of Anaesthesiologist Class 4 or Class 5; 7. Scrotal hernia (cannot be corrected laparoscopically); 8. Patient is unable to speak Dutch; 9. Physical activity: patient travels regularly during which professional medical help is not always accessible.

Design outcomes

Primary

MeasureTime frame
The mean of 4 pain/discomfort scores during a follow-up period of 3 years.

Secondary

MeasureTime frame
The Quality Adjusted Life Years (QALY) with quality weights measured with the EuroQol and in a sensitivity analysis with a transformed SF-36 utility weight, medical and non-medical costs and the event-free survival at 3 years.

Contacts

Public ContactJ.F. Lange

Erasmus Medical Center, Department of Surgery, P.O.Box 2040

j.lange@erasmusmc.nl+31 (0)10 4634593

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)